Top Things to Know: Peripheral Artery Disease in Acute Care Settings: Diagnosis and management of common presentations and emergencies
Updated: November 16, 2026
Prepared by Kevin J. Mercer, PharmD, MPH, FCCM, Science & Medicine Advisor, American Heart Association
- Peripheral artery disease (PAD) is common in hospitalized patients, and even when it is not the reason for admission, it meaningfully increases the risk of vascular complications, limb loss, and death during acute cardiovascular care.
- PAD often presents atypically or without symptoms in older adults, so a high index of suspicion is warranted even when classic claudication is absent, especially since nearly 1 in 5 octogenarians are affected.
- Older, frail patients with PAD are especially vulnerable to polypharmacy-related harm, and a structured medication review by a geriatric pharmacist, including deprescribing of nonessential agents, can help prevent iatrogenic complications.
- Medical therapy for PAD now targets limb outcomes as well as cardiovascular events, and hospitalization is a valuable but often missed opportunity to start these therapies, such as oral semaglutide, which reduced major adverse limb events.
- Because PAD impairs arterial perfusion, hospitalized patients are prone to new or worsening wounds, making regular skin checks, pressure offloading, and nursing vigilance essential to prevent limb-threatening complications.
- Complex PAD decisions, especially for chronic limb-threatening ischemia (CLTI), benefit from an institutional multidisciplinary vascular team, similar in concept to a multidisciplinary heart team, with palliative care integrated when amputation, revascularization, and goals of care must be weighed together.
- Vascular specialist access varies widely by region, and documented disparities in statin prescribing and revascularization outcomes make arranging outpatient vascular follow-up an important step whenever PAD is recognized during hospitalization.
- Patients with PAD face substantially elevated risk of vascular access complications during catheterization and mechanical circulatory support (MCS), including limb ischemia in about 1 in 10 patients receiving a percutaneous ventricular assist device, and bleeding or limb ischemia in up to 40% of those on extracorporeal membrane oxygenation (ECMO), making protocol-driven, ultrasound-guided access technique essential.
- Acute limb ischemia (ALI) is a true vascular emergency, marked by the classic 6 Ps (pain, pallor, pulselessness, paresthesia, paralysis, and poikilothermia), that should be recognized primarily by bedside examination and treated with urgent revascularization to prevent irreversible tissue loss.
- Despite compelling trial data supporting agents such as rivaroxaban, PCSK9 inhibitors, and GLP-1 receptor agonists, adoption of these limb-protective therapies in PAD remains low, marking an important target for future implementation and quality-improvement efforts.
Citation
Rymer JA, Banerjee S, Beckman J, Damluji AA, McGinigle KL, Kirksey L, Parikh SA, Sullivan AE, Trigoboff-Kohlman D, Wilkins L, Secemsky E; on behalf of the American Heart Association Acute Cardiac Care and General Cardiology Science Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Peripheral Vascular Disease; and Council on Quality of Care and Outcomes Research. Peripheral artery disease in acute care settings: diagnosis and management of common presentations and emergencies: a scientific statement from the American Heart Association. Circulation. Published online November 16, 2026. doi: 10.1161/CIR.0000000000001479